Sangamo BioSciences | SGMO - Devedores Comerciais

Preço das Ações
0.32
Mudança Diária
-0.01 -2.05%
Mensal
-31.24%
Anual
-62.66%
Q1 Previsão
0.32




Devedores Comerciais Alterar Data
Alaunos Therapeutics USD 2K 0 2025-06
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Alterity Therapeutics Limited AUD 8.67M 1.59M 2023-06
Amgen USD 9.57B 1.08B 2025-12
Bayer EUR 14.19B 720M 2025-12
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
Biogen USD 1.85B 234M 2025-09
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Cipla INR 74.61B 19.39B 2025-09
Clal Biotechnology ILS 3.75M 186K 2022-12
Compugen USD 2.38M 448K 2025-12
CSL USD 4.32B 1.35B 2025-12
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Grifols EUR 1B 285.88M 2025-12
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
J&J USD 17.61B 235M 2025-09
Karyopharm Therapeutics USD 31.78M 6.82M 2024-09
Merck USD 12.12B 596M 2025-09
Novartis USD 12.29B 3.3B 2025-12
Omeros USD 8.08M 440K 2024-06
Pfizer USD 18.12B 2.02B 2025-09
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 397M 100M 2025-12
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Tectonic Therapeutic USD 0 270K 2023-12
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12